Xeltis
Clinical trials sponsored by Xeltis, explained in plain language.
-
Pioneering heart graft trial begins in humans
Disease control ENROLLING_BY_INVITATIONThis study is testing a new type of artificial graft for coronary artery bypass surgery in patients with multi-vessel heart disease. It's the first time this specific device is being used in humans, aiming to see if it's safe and works as intended. The study will follow 20 patien…
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New lifeline for kidney patients: testing a better dialysis graft
Disease control ENROLLING_BY_INVITATIONThis study is testing a new synthetic tube, called the aXess graft, for patients with end-stage kidney disease who need hemodialysis but are not good candidates for the standard surgical connection (a fistula). The goal is to see if this new graft is safe and works well as a long…
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC